Inventor · disambiguated record
Qiyong Peter Liu
Also filed as: LIU QIYONG P · LIU QIYONG PETER
16 granted patents·20 pending applications·195 citations·filing 2002–2024
93Inventor score
Top patents by PatentIndex Score
36 records- 0197US9561184B2Methods and systems for multi-stage drying of plasmaVELICO MEDICAL INC·Filed 2015·Granted Feb 7, 2017·51 cites·20 claims
- 0296US11975274B2Blood plasma productVELICO MEDICAL INC·Filed 2022·Granted May 7, 2024·19 cites·16 claims
- 0395US12064518B2Formulations and methods for contemporaneous stabilization of active proteins during spray drying and storageVELICO MEDICAL INC·Filed 2021·Granted Aug 20, 2024·12 cites·30 claims
- 0495US11806431B2Formulations and methods for contemporaneous stabilization of active proteins during spray drying and storageVELICO MEDICAL INC·Filed 2021·Granted Nov 7, 2023·11 cites·30 claims
- 0595US11052045B2Formulations and methods for contemporaneous stabilization of active proteins during spray drying and storageVELICO MEDICAL INC·Filed 2016·Granted Jul 6, 2021·42 cites·39 claims
- 0695US9545379B2Formulations and methods for contemporaneous stabilization of active proteins during spray drying and storageVELICO MEDICAL INC·Filed 2015·Granted Jan 17, 2017·51 cites·20 claims
- 0783US2025108315A1Blood Plasma ProductVELICO MEDICAL INC·Filed 2024·Application pending·0 cites
- 0880US9788539B2Platelet protection solution having beta-galactosidase and sialidase inhibitorsVELICO MEDICAL INC·Filed 2016·Granted Oct 17, 2017·1 cites·25 claims
- 0980US2024374522A1Formulations And Methods For Contemporaneous Stabilization Of Active Proteins During Spray Drying And StorageVELICO MEDICAL INC·Filed 2024·Application pending·0 cites
- 1079US7993896B2Streptomyces griseoplanus α-galactosidases for removing immunodominant α-galactose monosaccharides from blood group B or AB reactive cellsVELICO MEDICAL INC·Filed 2010·Granted Aug 9, 2011·1 cites·2 claims
- 1176US12201920B2Blood plasma productVELICO MEDICAL INC·Filed 2023·Granted Jan 21, 2025·0 cites·17 claims
- 1274US7951552B2Method of preparing non-human tissues for xenotransplantation using α-galactosidaseVELICO MEDICAL INC·Filed 2006·Granted May 31, 2011·1 cites·2 claims
- 1374US7767415B2Compositions and methods for modifying blood cell carbohydratesVELICO MEDICAL INC·Filed 2002·Granted Aug 3, 2010·3 cites·4 claims
- 1471US10271541B2Platelet additive solution having a beta-galactosidase inhibitorVELICO MEDICAL INC·Filed 2017·Granted Apr 30, 2019·1 cites·16 claims
- 1571US8697411B2Streptomyces griseoplanus comprising an α-galactosidase for removing immunodominant α-galactose monosaccharides from blood group B or AB reactive cellsCLAUSEN HENRIK·Filed 2011·Granted Apr 15, 2014·1 cites·4 claims
- 1667US2024091667A1Pretreatment Of Plasma For Spray Drying And StorageVELICO MEDICAL INC·Filed 2023·Application pending·0 cites
- 1765US2024131062A1Spray Drying Process That Reduces PathogensVELICO MEDICAL INC·Filed 2023·Application pending·0 cites
- 1864US9609861B2Platelet additive solution having a β-galactosidase inhibitorVELICO MEDICAL INC·Filed 2013·Granted Apr 4, 2017·1 cites·18 claims
- 1964US2019203175A1Platelet Protection Solution Having a Beta-Galactosidase InhibitorVELICO MEDICAL INC·Filed 2018·Application pending·0 cites
- 2063US2024131063A1Blood Plasma ProductVELICO MEDICAL INC·Filed 2023·Application pending·0 cites
- 2162US9034626B2Methods of preparing tissues for xenotransplantation using alpha-galactosidasesVELICO MEDICAL INC·Filed 2014·Granted May 19, 2015·0 cites·20 claims
- 2262US2019200602A1Platelet Additive Solution Having a Beta-Galactosidase InhibitorVELICO MEDICAL INC·Filed 2019·Application pending·0 cites
- 2361US2019246629A1Platelet Storage and Reduced Bacterial Proliferation In Platelet Products Using A Sialidase InhibitorVELICO MEDICAL INC·Filed 2019·Application pending·0 cites
- 2461US2018000066A1Platelet Protection Solution Having Beta-Galactosidase and Sialidase InhibitorsVELICO MEDICAL INC·Filed 2017·Application pending·0 cites
- 2560US2024042070A1Nanoparticles and template directed rig-i agonist precursor compositions and uses thereof for cancer therapyTRANSCODE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2660US2014220553A1Enzymatic Conversion of Blood Group A, B, and AB Red Blood Cells Using alpha-N-Acetylgalactosaminidases and alpha-Galactosidases with Unique Substrate Specificities and Kinetic PropertiesVELICO MEDICAL INC·Filed 2014·Application pending·0 cites
- 2759US2024091155A1Pretreatment Of Plasma For Spray Drying And StorageVELICO MEDICAL INC·Filed 2022·Application pending·0 cites
- 2858US2016000064A1Platelet Storage and Reduced Bacterial Proliferation in Platelet Products Using a Sialidase InhibitorVELICO MEDICAL INC·Filed 2015·Application pending·0 cites
- 2957US2024167022A1Template directed immunomodulation for cancer therapyTRANSCODE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3056US2016145573A1Platelet Protection Solution Having a Beta-Galactosidase InhibitorVELICO MEDICAL INC·Filed 2016·Application pending·0 cites
- 3156US2005208655A1Blood cells having modified antigenicityCLAUSEN HENRIK·Filed 2005·Application pending·0 cites
- 3252US2012321722A1Platelet Storage and Reduced Bacterial Proliferation In Platelet Products Using A Sialidase InhibitorLIU QIYONG PETER·Filed 2012·Application pending·0 cites
- 3348US2012321601A1Increased In Vivo Circulation Time of Platelets After Storage With A Sialidase InhibitorLIU QIYONG PETER·Filed 2012·Application pending·0 cites
- 3445US8883478B2Methods of preparing tissues for xenotransplantation using α-galactosidasesLIU QIYONG PETER·Filed 2010·Granted Nov 11, 2014·0 cites·20 claims
- 3543US2017367322A1Reconstitution Solution For Spray-Dried PlasmaVELICO MEDICAL INC·Filed 2017·Application pending·0 cites
- 3640US2017370952A1Reconstitution Solution for Spray-Dried PlasmaVELICO MEDICAL INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qiyong Peter Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →